Article

Development and validation of a LRP1B mutation-associated prognostic model for hepatocellular carcinoma

2021-05-03

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose:</bold> To develop a LRP1B gene mutation based prognostic model for hepatocellular carcinoma (HCC) patients risk prediction. <bold>Methods:</bold> The LRP1B gene mutation rate was calculated from HCC patient samples. Meanwhile, differentially expressed genes according to LRP1B mutant were screened out for prognostic model establishment. Based on this innovative model, HCC...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3a3f54ac-309b-5b42-a573-3ee11606b8ff
DOI: 10.21203/rs.3.rs-266054/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development and validation of a LRP1B mutation-associated prognostic model for hepatocellular carcinomaDOI 10.21203/rs.3.rs-266054/v1Read

Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma.Semantic proximity Read

LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinomaSemantic proximity Read

CTNNB1-mutation-related immune gene prognostic model (CMRIPM) for hepatocellular carcinoma: Development and validationSemantic proximity Read

LRP1B mutation associates with increased tumor mutation burden and inferior prognosis in liver hepatocellular carcinoma.Semantic proximity Read

A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular CarcinomaSemantic proximity Read

The immune-related gene-based prognostic index predicts the prognosis and effect of immune checkpoint inhibitors in hepatocellular carcinomaSemantic proximity Read

A gene mutation-based risk model for prognostic prediction in liver metastases.Semantic proximity Read

Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinomaSemantic proximity Read

Diagnosis and prognosis models for hepatocellular carcinoma patient's management based on tumor mutation burden.Semantic proximity Read

Clinical and Prognostic Implications of an Immune-Related Risk Model Based on TP53 Status in Lung AdenocarcinomaSemantic proximity Read

Construction of a novel tumor mutation burden-related mRNA signature for prognosis prediction in laryngeal squamous cell carcinoma.Semantic proximity Read

Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics AnalysisSemantic proximity Read